s6y
Company name or ticker
Search
Assertio Therapeutics, Inc
8-K
Director or officer change
Filed
Friday, October 7, 2016
Period
Oct 4, 2016
Accession number
0001104659-16-149360
Documents
Current report filing
8-K
On sec.gov
Filing index
All files
Complete submission text
SGML header